Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
Status:
NOT_YET_RECRUITING
Trial end date:
2030-03-31
Target enrollment:
Participant gender:
Summary
This is a multi-site study of the pharmacodynamic effects and efficacy of metformin in children and young adults with recurrent or progressive Posterior Fossa Group A (PFA) ependymoma.
Phase:
PHASE2
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Pediatric Neuro-Oncology Consortium The Lilabean Foundation, Inc.
Treatments:
Magnetic Resonance Spectroscopy Metformin Specimen Handling